Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: The Effects of Bifidobacterium-based Probiotics in Reducing Blood Pressure in Middle-aged Chinese With Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at The University of Hong Kong is investigating whether bifidobacterium-based probiotics can reduce blood pressure in middle-aged Chine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium-based probiotic (Bifidobacterium-based probiotic)

Snippet

Sponsor: The University of Hong Kong | Conditions: Hypertension | Phase 1 | Status: NOT_YET_RECRUITING